Repare Therapeutics Company Insiders

Repare Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of (0.4019) % which means that it has lost $0.4019 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7164) %, meaning that it created substantial loss on money invested by shareholders. Repare Therapeutics' management efficiency ratios could be used to measure how well Repare Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.5 in 2025. Return On Capital Employed is likely to drop to -0.65 in 2025. At this time, Repare Therapeutics' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 9.4 M in 2025, whereas Net Tangible Assets are likely to drop slightly above 173 M in 2025. Common Stock Shares Outstanding is likely to drop to about 37 M in 2025. Net Loss is likely to drop to about (27.4 M) in 2025

Repare Therapeutics Workforce Comparison

Repare Therapeutics Insider Trading

Repare Therapeutics Notable Stakeholders

The success or failure of an entity such as Repare Therapeutics often depends on how effective the management is. Repare Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Repare management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Repare management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Repare Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Repare Therapeutics. Check Repare Therapeutics' Beneish M Score to see the likelihood of Repare Therapeutics' management manipulating its earnings.

When running Repare Therapeutics' price analysis, check to measure Repare Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repare Therapeutics is operating at the current time. Most of Repare Therapeutics' value examination focuses on studying past and present price action to predict the probability of Repare Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repare Therapeutics' price. Additionally, you may evaluate how the addition of Repare Therapeutics to your portfolios can decrease your overall portfolio volatility.